CoreAge Rx
The best ingredient thinking in the register, sold behind the thinnest product pages. A copper peptide dosed four times above its studied concentration, tretinoin correctly paired with niacinamide, an estriol matched to the pivotal study, a three-pathway pigment stack. Not one product publishes an ingredient list, a container size, or any clinical data.
MODEL
Online questionnaire, physician review, US compounding, monthly subscription. Skincare sits alongside semaglutide, tirzepatide, NAD+ and sermorelin.
The brand verdict
Somebody here is pharmacologically literate and it shows in every one of the five formulas. A copper peptide dosed at four times the concentration used in its best controlled study. Tretinoin paired with niacinamide, which is the correct construction because tolerability governs adherence and adherence governs outcomes. Estriol at exactly the strength used in the pivotal topical pilot. A BHA-plus-niacinamide-plus-urea stack that reaches the follicle and offsets its own irritation. A pigment formula attacking three separate pathways, one of them melanosome transfer rather than synthesis. These are the choices we spend most reviews asking other companies to make.
Where a real drug is present the prescriber is doing real work. Estriol is an oestrogen, tretinoin is a prescription retinoid, and hydroquinone is prescription-only in the United States. Three of the five genuinely belong behind a clinician, and the intake, the compounding and the delivery are included in prices that run from $42 to $64.99 a month — cheaper than a single dermatology visit in most of the country.
On the other two the physician review is a dispensing service rather than a regulatory requirement, and the company should say so. Copper peptide is a cosmetic ingredient; salicylic acid at monograph strength is a drugstore product. Framed as supervised dispensing, both are defensible. Framed as though the prescription were pharmacologically necessary — the stated reason we found is that the formula contains active ingredients — it claims something the pharmacology does not support.
The consistent gap across all five is not the formulas. It is the pages. No product publishes a full ingredient list, a container size or any clinical data, only Time Out quantifies every active it names, and where a contraindication is the single most important fact — breast cancer for a topical oestrogen, pregnancy for a retinoid, ochronosis and a stop date for hydroquinone — none appears. Each of those is a line of copy rather than a reformulation, which is why these reviews read the way they do: good products, underserved by their own disclosure.
- Bounce Back's copper peptide at 0.2% is four times the concentration used in the best controlled study we found — the best-dosed single active in the register.
- Smooth Move pairs tretinoin with niacinamide, the correct construction, and positions it at night with daily sunscreen instructed.
- Time Out's estriol at 0.3% matches the pivotal pilot study exactly — somebody read the paper.
- Time Out publishes a concentration for every active it names, which is the standard we have been asking the category to meet.
- Pore Favor's ingredient logic is genuinely sound: a lipid-soluble BHA that reaches the follicle, niacinamide for sebum and inflammation, urea as a keratolytic humectant.
- Spot On attacks pigment by three separate pathways, including one acting on melanosome transfer rather than synthesis, and tells you to treat affected areas only.
- Directions are consistently good across the range: thin layer, clean dry skin, start slowly, avoid eyes and broken skin, wear sunscreen during the day.
- Prices include the intake, the physician review, the compounding and delivery, and run below a single dermatology consultation in most of the country.
- The company names its medical entities in the site footer, which is more corporate transparency than many telehealth brands offer.
The range
- R-132026-07-25
Smooth Move
TRETINOIN · NIACINAMIDE · VITAMIN CReal tretinoin, correctly paired with niacinamide — the best-evidenced construction in topical anti-ageing — at $42 a month with the prescriber, the compounding and delivery included. What the page still will not say is how much tretinoin, and it does not carry the pregnancy contraindication. We do, below.
RECOMMENDED$42 PER MONTH
- R-102026-07-25
Bounce Back
COPPER PEPTIDE 0.2%Copper peptide at 0.2% — four times the concentration used in the best controlled study we could find, and the best-dosed single active we have assessed. Compounded in the US, dispensed after a physician review, positioned for night-time barrier work. The full ingredient list is still not published.
RECOMMENDED$64.99 PER MONTH
- R-122026-07-25
Time Out
ESTRIOL 0.3%Every active quantified — estriol 0.3%, vitamin C 5%, hydrolysed hyaluronic acid 0.5% — with the estriol matched exactly to the concentration used in the pivotal topical pilot. A real prescription for a real hormone, which is also why the contraindications below matter more than anything else on this page.
CONDITIONAL$48 PER MONTH
- R-142026-07-25
Spot On
HYDROQUINONE · KOJIC ACID · NIACINAMIDEHydroquinone, kojic acid and niacinamide — three complementary routes to the same pigment, with the strongest depigmenting agent in general use at the centre of it. Two things the page leaves out and you should insist on: the hydroquinone percentage, and a stop date. This is a cycled therapy.
CONDITIONAL$54.99 PER MONTH
- R-112026-07-25
Pore Favor
CLARIFYING FORMULASalicylic acid, zinc oxide, niacinamide and urea — a coherent, well-matched stack for oily, congested skin, compounded and dispensed after a physician review at $42 a month. Everything in it sits inside over-the-counter limits as published, and not one concentration is given.
CONDITIONAL$42 PER MONTH
What repeats across the range
These are the findings a single review cannot make. Each one appears in more than one product, and each is drawn from the reviews above rather than from an impression of the brand.
- 01
The doses are chosen, not decorated
Bounce Back runs copper peptide at 0.2% — four times the 0.05% used in the best controlled study we found, and inside the 0.2–2% cosmetic preparation range rather than at the token end. Time Out runs estriol at 0.3%, precisely the strength used in the pivotal pilot. After nine reviews of actives dosed below their trial range, two products here are dosed at or above it.
- 02
The pairings address the reason treatments fail
Smooth Move puts niacinamide with tretinoin, which is the single most useful thing a compounder can do to a retinoid, because irritation in week three is what ends retinoid courses. Spot On puts niacinamide with hydroquinone for the same reason, and adds a third pathway. Pore Favor offsets a BHA with niacinamide and urea. Somebody is designing for adherence rather than for the label.
- 03
Three prescriptions are real; two are a dispensing service
Estriol, tretinoin and hydroquinone all genuinely require a prescriber. Copper peptide is permitted in cosmetics without concentration limits in both the US and the EU, and salicylic acid is Category I over the counter at 0.5–2%. For those two the consultation is supervised dispensing with delivery attached — a real service, worth what it is worth, and not a regulatory necessity.
- 04
Only one product quantifies everything it names
Time Out publishes a concentration for all three of its actives. Bounce Back publishes the one that matters. Smooth Move contains tretinoin across a tenfold range and does not say where; Spot On replaces the hydroquinone percentage with the phrase 'prescription-strength'; Pore Favor gives four ingredient names and no numbers. In every case the number exists — it is on the label the pharmacy prints — and it belongs on the page.
- 05
The contraindications are the missing copy, not the missing science
A topical oestrogen sold to post-menopausal women with no mention of breast cancer, clotting or unexplained bleeding. A retinoid with no pregnancy warning. Hydroquinone with no mention of exogenous ochronosis and no stop date for a therapy conventionally cycled off after two to three months. We have printed all of it in the reviews, and every one of those omissions is a sentence long.
- 06
No container size, and no clinical data, anywhere
Not one of the five publishes a fill volume, so cost per application cannot be computed for any product in the range, and none cites a single study for the finished product. The monthly prices are fair for supervised compounding; whether they are fair per gram is unknowable from what is published.
Disclosure scorecard
Not what is in the product — what the company publishes about it, and where. “Findable” means the concentration exists somewhere, such as a help-centre article, rather than on the page you buy from.
SCROLL THE TABLE SIDEWAYS
| PRODUCT | CONC. ON PAGE | CONC. FINDABLE | CONTRA-INDICATIONS | SIZE | SIDE EFFECTS |
|---|---|---|---|---|---|
| Time Out | YES | YES | NO | NO | NO |
| Bounce Back | PART | PART | NO | NO | NO |
| Smooth Move | NO | NO | NO | NO | NO |
| Pore Favor | NO | NO | NO | NO | NO |
| Spot On | NO | NO | NO | NO | NO |
If you buy one
Smooth Move
Buy it. The formula, the disclosure and the price all hold up.
Pore Favor
Worth buying for a specific person with a specific problem. Read who.